Local Institution - 1002 — Staten Island, New York

Local Institution - 1002 is a clinical research site located in Staten Island, New York, United States 10314-1607.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 1002 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Psychosis Associated With Alzheimer's Disease.

Sponsors: Karuna Therapeutics, Inc., a Bristol Myers Squibb company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 1002?

Local Institution - 1002 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 1002 conducted?

Local Institution - 1002 has 1 clinical trials on record, with 1 currently active. Their work covers Psychosis Associated With Alzheimer's Disease.

Is Local Institution - 1002 accredited by Crixeo Health?

Local Institution - 1002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 1002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.